Evidence map›Paper›PMID 40332127›Full record

ReviewInternational journal of molecular sciences2025

Positive Regulation of Cellular Proteins by Influenza Virus for Productive Infection.

Jiayu Cong, Ting Wang, Bumsuk Hahm, Chuan Xia

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jiayu CongDepartment of Pathogen Biology and Microecology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Ting WangDepartment of Bioengineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Bumsuk HahmDepartments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65212, USA.ORCID 0000-0002-0083-6129
Chuan XiaDepartment of Pathogen Biology and Microecology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.

Funding

Interplay between influenza virus and S1P-metabolizing enzymesR01AI162631 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI HAHM, BUMSUK · 2021 to 2025
$2.2M
Regulation of host immunity to impact virus persistenceR01AI153076 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI HAHM, BUMSUK · 2021 to 2025
$2.1M
NIAID NIH HHS R01 AI153076NIAID NIH HHS R01 AI162631NIH/NIAID R01AI153076NIH/NIAID R01AI162631Scientific Research Fund of Liaoning Provincial Department of Education LJKMZ20221257
6 · The paper itself

Abstract

Influenza viruses cause annual epidemics and occasional pandemics through respiratory tract infections, giving rise to substantial morbidity and mortality worldwide. Influenza viruses extensively interact with host cellular proteins and exploit a variety of cellular pathways to accomplish their infection cycle. Some of the cellular proteins that display negative effects on the virus are degraded by the virus. However, there are also various proteins upregulated by influenza at the expression and/or activation levels. It has been well-established that a large number of host antiviral proteins such as type I interferon-stimulated genes are elevated by viral infection. On the other hand, there are also many cellular proteins that are induced directly by the virus, which are considered as pro-viral factors and often indispensable for rigorous viral propagation or pathogenicity. Here, we review the recent advances in our understanding of the cellular factors deemed to be upregulated and utilized by the influenza virus. The focus is placed on the functions of these pro-viral proteins and the mechanisms associated with promoting viral amplification, evading host immunity, or enhancing viral pathogenicity. Investigating the process of how influenza viruses hijack cellular proteins could provide a framework for inventing the host-factor-targeted drugs to conquer influenza.

Indexed as

Host-Pathogen InteractionsInfluenza, HumanOrthomyxoviridaeAnimalsHumansViral ProteinsVirus ReplicationViral Proteinsimmune evasioninfluenza virussignaling pathwaysvirus–host interactionvirus life cycle

Identifiers

PMID40332127
PMCPMC12027300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.